Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Stockbridge Capital Group is a prominent real estate investment management firm that has established a significant presence in the life sciences sector through its dedicated life science real estate platform. The company focuses on acquiring, developing, and managing specialized laboratory and office spaces tailored to the needs of biotechnology, pharmaceutical, and healthcare organizations. By providing mission-critical infrastructure in key innovation hubs, Stockbridge supports the operational requirements of companies ranging from early-stage startups to established global pharmaceutical leaders. Their portfolio includes high-specification R&D facilities and manufacturing sites designed to meet stringent regulatory and technical standards. Stockbridge's strategic investments in life science properties facilitate the growth of the broader healthcare ecosystem by offering flexible and scalable real estate solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Stockbridge.